BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31157509)

  • 1. A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counseling.
    Venier RE; Maurer LM; Kessler EM; Ranganathan S; McGough RL; Weiss KR; Malek MM; Meade J; Tersak JM; Bailey KM
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27824. PubMed ID: 31157509
    [No Abstract]   [Full Text] [Related]  

  • 2. BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
    Maurer LM; Daley JD; Mukherjee E; Venier RE; Julian CM; Bailey NG; Jacobs MF; Kumar-Sinha C; Raphael H; Periyapatna N; Weiss K; Janeway KA; Mody R; Lucas PC; McAllister-Lucas LM; Bailey KM
    Cancer Res Commun; 2022 Apr; 2(4):220-232. PubMed ID: 36187937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.
    Jiang Y; Janku F; Subbiah V; Angelo LS; Naing A; Anderson PM; Herzog CE; Fu S; Benjamin RS; Kurzrock R
    Oncotarget; 2013 Jun; 4(6):884-9. PubMed ID: 23800680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Variation and Somatic Alterations in Ewing Sarcoma.
    Machiela MJ; Grünewald TGP
    Methods Mol Biol; 2021; 2226():3-14. PubMed ID: 33326089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there more to BARD1 than BRCA1?
    Irminger-Finger I; Jefford CE
    Nat Rev Cancer; 2006 May; 6(5):382-91. PubMed ID: 16633366
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.
    Mackintosh C; Ordóñez JL; García-Domínguez DJ; Sevillano V; Llombart-Bosch A; Szuhai K; Scotlandi K; Alberghini M; Sciot R; Sinnaeve F; Hogendoorn PC; Picci P; Knuutila S; Dirksen U; Debiec-Rychter M; Schaefer KL; de Álava E
    Oncogene; 2012 Mar; 31(10):1287-98. PubMed ID: 21822310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.
    De Brakeleer S; De Grève J; Desmedt C; Joris S; Sotiriou C; Piccart M; Pauwels I; Teugels E
    Clin Genet; 2016 Mar; 89(3):336-40. PubMed ID: 26010302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.
    Henrich IC; Jain K; Young R; Quick L; Lindsay JM; Park DH; Oliveira AM; Blobel GA; Chou MM
    Cancer Res; 2021 Apr; 81(8):2171-2183. PubMed ID: 33558334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma.
    Brohl AS; Patidar R; Turner CE; Wen X; Song YK; Wei JS; Calzone KA; Khan J
    Genet Med; 2017 Aug; 19(8):955-958. PubMed ID: 28125078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPRD copy number variants and Ewing's sarcoma: Strengthening the association and therapeutic implications.
    Saskin A; Seath K; Tihy F; Lemyre E; Davis J; Halal F; Armstrong L
    Cancer Genet; 2019 Jun; 235-236():28-30. PubMed ID: 31072725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
    Ratajska M; Matusiak M; Kuzniacka A; Wasag B; Brozek I; Biernat W; Koczkowska M; Debniak J; Sniadecki M; Kozlowski P; Klonowska K; Pilyugin M; Wydra D; Laurent G; Limon J; Irminger-Finger I
    Oncol Rep; 2015 Nov; 34(5):2609-17. PubMed ID: 26329992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing sarcoma.
    Choi EY; Gardner JM; Lucas DR; McHugh JB; Patel RM
    Semin Diagn Pathol; 2014 Jan; 31(1):39-47. PubMed ID: 24680181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient.
    Zheng Y; Li B; Pan D; Cao J; Zhang J; Wang X; Li X; Hou W; Bao D; Ren L; Yang J; Wang S; Qiu Y; Zhou F; Liu Z; Zhu S; Zhang L; Qing T; Wang Y; Yu Y; Wu J; Hu X; Shi L
    Breast Cancer Res; 2021 May; 23(1):53. PubMed ID: 33933153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.
    Spahn L; Petermann R; Siligan C; Schmid JA; Aryee DN; Kovar H
    Cancer Res; 2002 Aug; 62(16):4583-7. PubMed ID: 12183411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ewing sarcoma: a tough road to clinically relevant biomarkers.
    Shukla N
    Pediatr Blood Cancer; 2015 May; 62(5):741-2. PubMed ID: 25586427
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.
    Tirode F; Surdez D; Ma X; Parker M; Le Deley MC; Bahrami A; Zhang Z; Lapouble E; Grossetête-Lalami S; Rusch M; Reynaud S; Rio-Frio T; Hedlund E; Wu G; Chen X; Pierron G; Oberlin O; Zaidi S; Lemmon G; Gupta P; Vadodaria B; Easton J; Gut M; Ding L; Mardis ER; Wilson RK; Shurtleff S; Laurence V; Michon J; Marec-Bérard P; Gut I; Downing J; Dyer M; Zhang J; Delattre O;
    Cancer Discov; 2014 Nov; 4(11):1342-53. PubMed ID: 25223734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking germline and somatic variation in Ewing sarcoma.
    Gomez NC; Davis IJ
    Nat Genet; 2015 Sep; 47(9):964-5. PubMed ID: 26313223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.